IFF to Release First Quarter 2019 Results May 6
International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of scent, taste, and nutrition, announced that it will release its first quarter 2019 earnings results following the market close on Monday, May 6, 2019. The management team will host a live webcast on Tuesday, May 7, 2019 at 10:00 a.m. ET to discuss results and outlook with the investor community.
Investors may access the live webcast and accompanying slide presentation on the Company's website at ir.iff.com. For those unable to listen to the live webcast, a recorded version will be made available for replay.
International Flavors & Fragrances Inc. (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF) is a leading innovator of scent, taste, and nutrition, with 97 manufacturing facilities, 105 R&D centers, and 39,000 customers globally. At the heart of our company, we are fueled by a sense of discovery, constantly asking “what if?”. That passion for exploration drives us to co-create unique products that consumers experience in more than 90,000 unique products sold annually. Our 13,000 team members globally take advantage of leading consumer insights, naturals exploration, research and development, creative expertise, and customer intimacy to develop differentiated offerings for consumer products.
International Flavors & Fragrances Inc.
About Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ADVA14.10.2019 18:02:06 CEST | Press release
ADVA recognized as a Leaders Board Partner in the Intel® Network Builders’ Program
CA-VERIMATRIX14.10.2019 17:42:05 CEST | Press release
Ksmartech, Leading Korean Developer Partners with Verimatrix to Offer Powerful App Security Technology for Automotive, Financial Markets
SERVIER14.10.2019 14:02:08 CEST | Press release
Analysis of Patients With Prior Gastrectomy Treated With LONSURF® (trifluridine/tipiracil) Published in JAMA Oncology
ISL14.10.2019 12:51:06 CEST | Press release
‘Energy’ Pulses Through Superstar Swimmers in International Swimming League Leg in Naples
LIBELIUM14.10.2019 12:42:06 CEST | Press release
Libelium Focuses Its Business on Professional IoT Technology Closing the Electronics Maker Division "Cooking Hacks"
CA-SOTIO14.10.2019 12:10:03 CEST | Press release
PPF and SOTIO Invest $6.5 Million in MaveriX Oncology and its Lead Program MVX-5005
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom